Multimillion-dollar drug yanked from market connected to dangerous brain inflammation cases in U.S.
March 07, 2018 at 15:20 PM EST
The FDA is reviewing whether a type of brain inflammation called encephalitis linked to Biogen and AbbVie’s MS drug Zinbryta was a result of a known side effect of the therapy or has another cause, a FDA spokesperson told MarketWatch